Topics:
Radiation Oncology • Genitourinary Cancers
If a man has been on a 5-alpha reductase inhibitor for urinary symptoms prior to prostate radiation therapy, is there value in continuing it after radiation therapy?
In particular, for men who have no strong indication for ADT?
Answer from: Radiation Oncologist at Academic Institution
5-alpha reductase inhibitors, e.g. dutasteride, are indicated for the treatment of symptoms related to BPH and an enlarged prostate and have some efficacy for this indication, especially when combined with alpha blockers. 5-alpha reductase reduces a double bond in testosterone to create a more poten...
Sign in or Register to read more